PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 14, 2021Clinical Research in Cardiology33 citationsOpen Access

Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?

MPMiruna PopaMKMarc KottmaierERElena Risse

Key Result

Early recurrence of atrial tachyarrhythmia post-ablation strongly predicted late recurrence compared to no early recurrence (92.3% vs 43.8%; OR 16.8, 95% CI 6.184-45.797, P<0.001).

Study Design

Type

Cohort (n=207)

Structured PICO

Does early recurrence of atrial tachyarrhythmia predict late recurrence in patients with persistent atrial fibrillation undergoing catheter ablation?

P
Population
207 consecutive patients with persistent and long-standing persistent atrial fibrillation undergoing de novo pulmonary vein isolation (± atrial substrate ablation), mean age 66.4, 66.2% male.
I
Intervention
Early recurrence of atrial tachyarrhythmia (ERAT), defined as any atrial arrhythmia ≥ 30 s occurring within the first 30 days post-ablation.
C
Comparator
No early recurrence of atrial tachyarrhythmia (ERAT) within the first 30 days.
O
Outcome
Late recurrence (LR) of atrial arrhythmia determined during follow-up visits scheduled 1, 3, 6 and 12 months post-ablation using 7-day Holter ECGs.

Early recurrence of atrial tachyarrhythmia within 30 days of ablation for persistent AF is a strong independent predictor of late recurrence, challenging the assumption that it is merely a transient phenomenon.

Main Result

Effect estimate: OR 16.8 (95% CI 6.184-45.797)

Absolute Event Rate: 92.3% vs 43.8%

p-value: p=<0.001

Abstract

BACKGROUND: Early recurrence of atrial tachyarrhythmia (ERAT) is common after radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF), but its clinical significance in patients with persistent AF remains unclear. We sought to determine the predictive value of ERAT for rhythm outcome after RFCA for persistent AF. METHODS: The study included 207 consecutive patients (mean age 66.4 ± 10.7 years, male 66.2%) with persistent and long-standing persistent AF undergoing de novo pulmonary vein isolation (± atrial substrate ablation). All patients remained off antiarrhythmic drugs. ERAT was defined as any atrial arrhythmia ≥ 30 s occurring within the first 30 days. Late recurrence (LR) was determined during follow-up visits scheduled 1, 3, 6 and 12 months post-ablation using 7-day Holter ECGs. RESULTS: ERAT occurred in 143/207 (69.1%) patients as AF (60%) or atrial tachycardia (40%) and was persistent in 82% of cases. During a median follow-up of 22.2 months, LR occurred significantly more often in patients with ERAT than in patients without ERAT (92.3 vs. 43.8%, P < 0.001). The only independent predictors for LR were ERAT (OR 16.8, 95% CI 6.184-45.797, P < 0.001) and intraprocedural termination to sinus rhythm (OR 0.052, 95% CI 0.003-0.851, P = 0.038). Extending the blanking period from 30 to 90 days did not impact LR rates. CONCLUSION: ERAT following ablation of persistent AF is strongly associated with late arrhythmia recurrence, which challenges the assumption that ERAT represents merely a transient phenomenon. While limiting the blanking period to 30 days seems justified, the benefit of early re-ablations remains to be addressed in future studies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Popa et al. (2021) conducted a cohort in persistent and long-standing persistent atrial fibrillation (n=207). Early recurrence of atrial tachyarrhythmia (ERAT) vs. No ERAT was evaluated on Late recurrence (LR) of atrial arrhythmia (OR 16.8, 95% CI 6.184-45.797, p=<0.001). Early recurrence of atrial tachyarrhythmia post-ablation strongly predicted late recurrence compared to no early recurrence (92.3% vs 43.8%; OR 16.8, 95% CI 6.184-45.797, P<0.001).

synapsesocial.com/papers/6a0a5794fdd00ab7863dc9f7https://doi.org/10.1007/s00392-021-01934-8
Ask AI
Helpful
Bookmark
Share
View Full Paper